25 XP   0   0   10

MedMira Inc
Buy, Hold or Sell?

Let's analyse Medmira together

PenkeI guess you are interested in MedMira Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MedMira Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about MedMira Inc

I send you an email if I find something interesting about MedMira Inc.

Quick analysis of Medmira (30 sec.)










What can you expect buying and holding a share of Medmira? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.02
Expected worth in 1 year
$-0.02
How sure are you?
15.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-4.9%

For what price can you sell your share?

Current Price per Share
$0.06
Expected price per share
$0.035 - $0.0616
How sure are you?
50%

1. Valuation of Medmira (5 min.)




Live pricePrice per Share (EOD)

$0.06

Intrinsic Value Per Share

$-0.06 - $-0.02

Total Value Per Share

$-0.08 - $-0.04

2. Growth of Medmira (5 min.)




Is Medmira growing?

Current yearPrevious yearGrowGrow %
How rich?-$11.4m-$8.8m-$1.7m-16.6%

How much money is Medmira making?

Current yearPrevious yearGrowGrow %
Making money-$512.7k-$358.6k-$154k-30.1%
Net Profit Margin-1,060.1%-292.1%--

How much money comes from the company's main activities?

3. Financial Health of Medmira (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#959 / 1016

Most Revenue
#646 / 1016

Most Profit
#207 / 1016

Most Efficient
#815 / 1016

What can you expect buying and holding a share of Medmira? (5 min.)

Welcome investor! Medmira's management wants to use your money to grow the business. In return you get a share of Medmira.

What can you expect buying and holding a share of Medmira?

First you should know what it really means to hold a share of Medmira. And how you can make/lose money.

Speculation

The Price per Share of Medmira is $0.06. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medmira.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medmira, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.02. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medmira.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-1.4%0.00-1.2%0.00-0.9%0.00-0.8%0.00-1.1%
Usd Book Value Change Per Share0.00-1.4%0.00-1.2%0.001.4%0.00-0.3%0.00-0.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-1.4%0.00-1.2%0.001.4%0.00-0.3%0.00-0.5%
Usd Price Per Share0.01-0.05-0.09-0.09-0.06-
Price to Earnings Ratio-3.72--17.39--45.66--44.11--24.91-
Price-to-Total Gains Ratio-14.89--69.57--107.26--235.23--158.30-
Price to Book Ratio-0.73--3.14--7.12--6.26--4.39-
Price-to-Total Gains Ratio-14.89--69.57--107.26--235.23--158.30-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.06
Number of shares16666
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (16666 shares)-12.25-3.38
Gains per Year (16666 shares)-49.01-13.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-49-590-14-24
20-98-1080-27-38
30-147-1570-41-52
40-196-2060-54-66
50-245-2550-68-80
60-294-3040-81-94
70-343-3530-95-108
80-392-4020-108-122
90-441-4510-122-136
100-490-5000-135-150

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.039.00.02.5%4.085.07.04.2%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%6.034.00.015.0%18.078.00.018.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%1.00.095.01.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%6.034.00.015.0%18.078.00.018.8%

Fundamentals of Medmira

About MedMira Inc

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. In addition, the company offers VYRATM TriDemic antigen rapid test that distinguishes the three respiratory viruses, such as SARS-CoV-2, influenza, and respiratory syncytial virus that exhibit similar symptoms. It sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

Fundamental data was last updated by Penke on 2024-04-01 15:12:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of MedMira Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medmira earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • A Net Profit Margin of -662.1% means that $-6.62 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MedMira Inc:

  • The MRQ is -662.1%. The company is making a huge loss. -2
  • The TTM is -1,060.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-662.1%TTM-1,060.1%+398.0%
TTM-1,060.1%YOY-292.1%-768.0%
TTM-1,060.1%5Y-499.1%-561.0%
5Y-499.1%10Y-377.5%-121.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-662.1%-197.2%-464.9%
TTM-1,060.1%-210.4%-849.7%
YOY-292.1%-279.3%-12.8%
5Y-499.1%-436.8%-62.3%
10Y-377.5%-599.3%+221.8%
1.1.2. Return on Assets

Shows how efficient Medmira is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • -17.0% Return on Assets means that Medmira generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MedMira Inc:

  • The MRQ is -17.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.0%TTM-18.0%+1.0%
TTM-18.0%YOY-12.3%-5.7%
TTM-18.0%5Y-38.4%+20.4%
5Y-38.4%10Y-67.9%+29.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.0%-13.6%-3.4%
TTM-18.0%-12.9%-5.1%
YOY-12.3%-11.9%-0.4%
5Y-38.4%-14.2%-24.2%
10Y-67.9%-16.2%-51.7%
1.1.3. Return on Equity

Shows how efficient Medmira is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • 0.0% Return on Equity means Medmira generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MedMira Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--17.0%+17.0%
TTM--16.1%+16.1%
YOY--15.4%+15.4%
5Y--20.0%+20.0%
10Y--21.1%+21.1%

1.2. Operating Efficiency of MedMira Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medmira is operating .

  • Measures how much profit Medmira makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • An Operating Margin of -507.5% means the company generated $-5.07  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MedMira Inc:

  • The MRQ is -507.5%. The company is operating very inefficient. -2
  • The TTM is -614.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-507.5%TTM-614.9%+107.5%
TTM-614.9%YOY-214.4%-400.5%
TTM-614.9%5Y-317.6%-297.3%
5Y-317.6%10Y-250.9%-66.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-507.5%-286.1%-221.4%
TTM-614.9%-224.4%-390.5%
YOY-214.4%-288.4%+74.0%
5Y-317.6%-475.2%+157.6%
10Y-250.9%-624.7%+373.8%
1.2.2. Operating Ratio

Measures how efficient Medmira is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 6.07 means that the operating costs are $6.07 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of MedMira Inc:

  • The MRQ is 6.075. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.064. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.075TTM7.064-0.990
TTM7.064YOY3.125+3.940
TTM7.0645Y4.139+2.926
5Y4.13910Y3.556+0.582
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0752.997+3.078
TTM7.0643.247+3.817
YOY3.1253.766-0.641
5Y4.1395.675-1.536
10Y3.5567.857-4.301

1.3. Liquidity of MedMira Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medmira is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.15 means the company has $0.15 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of MedMira Inc:

  • The MRQ is 0.154. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.124. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.154TTM0.124+0.029
TTM0.124YOY0.134-0.010
TTM0.1245Y0.088+0.036
5Y0.08810Y0.174-0.086
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1543.930-3.776
TTM0.1244.251-4.127
YOY0.1345.436-5.302
5Y0.0886.045-5.957
10Y0.1746.363-6.189
1.3.2. Quick Ratio

Measures if Medmira is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • A Quick Ratio of 0.14 means the company can pay off $0.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MedMira Inc:

  • The MRQ is 0.140. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.109. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.140TTM0.109+0.031
TTM0.109YOY0.115-0.006
TTM0.1095Y0.056+0.053
5Y0.05610Y0.130-0.074
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1403.629-3.489
TTM0.1094.065-3.956
YOY0.1155.397-5.282
5Y0.0565.993-5.937
10Y0.1306.277-6.147

1.4. Solvency of MedMira Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medmira assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medmira to Biotechnology industry mean.
  • A Debt to Asset Ratio of 4.45 means that Medmira assets are financed with 444.8% credit (debt) and the remaining percentage (100% - 444.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MedMira Inc:

  • The MRQ is 4.448. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 4.715. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.448TTM4.715-0.266
TTM4.715YOY4.022+0.692
TTM4.7155Y11.262-6.548
5Y11.26210Y12.365-1.103
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4480.332+4.116
TTM4.7150.334+4.381
YOY4.0220.268+3.754
5Y11.2620.366+10.896
10Y12.3650.390+11.975
1.4.2. Debt to Equity Ratio

Measures if Medmira is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MedMira Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.381-0.381
TTM-0.390-0.390
YOY-0.334-0.334
5Y-0.434-0.434
10Y-0.466-0.466

2. Market Valuation of MedMira Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Medmira generates.

  • Above 15 is considered overpriced but always compare Medmira to the Biotechnology industry mean.
  • A PE ratio of -3.72 means the investor is paying $-3.72 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MedMira Inc:

  • The EOD is -18.456. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.722. Based on the earnings, the company is expensive. -2
  • The TTM is -17.393. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.456MRQ-3.722-14.734
MRQ-3.722TTM-17.393+13.671
TTM-17.393YOY-45.655+28.262
TTM-17.3935Y-44.109+26.716
5Y-44.10910Y-24.912-19.197
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-18.456-2.315-16.141
MRQ-3.722-2.560-1.162
TTM-17.393-2.664-14.729
YOY-45.655-4.122-41.533
5Y-44.109-6.258-37.851
10Y-24.912-6.108-18.804
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MedMira Inc:

  • The EOD is -21.004. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.236. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -41.931. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.004MRQ-4.236-16.768
MRQ-4.236TTM-41.931+37.695
TTM-41.931YOY33.681-75.612
TTM-41.9315Y58.209-100.140
5Y58.20910Y13.265+44.945
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-21.004-3.067-17.937
MRQ-4.236-3.251-0.985
TTM-41.931-3.545-38.386
YOY33.681-5.595+39.276
5Y58.209-8.315+66.524
10Y13.265-8.708+21.973
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medmira is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.73 means the investor is paying $-0.73 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of MedMira Inc:

  • The EOD is -3.643. Based on the equity, the company is expensive. -2
  • The MRQ is -0.735. Based on the equity, the company is expensive. -2
  • The TTM is -3.144. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.643MRQ-0.735-2.909
MRQ-0.735TTM-3.144+2.409
TTM-3.144YOY-7.119+3.976
TTM-3.1445Y-6.259+3.115
5Y-6.25910Y-4.388-1.871
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.6431.905-5.548
MRQ-0.7352.111-2.846
TTM-3.1442.095-5.239
YOY-7.1192.836-9.955
5Y-6.2593.443-9.702
10Y-4.3883.794-8.182
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of MedMira Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.001-10%0.001-197%0.000-75%0.000-62%
Book Value Per Share---0.016-0.015-8%-0.013-23%-0.015-10%-0.011-31%
Current Ratio--0.1540.124+24%0.134+15%0.088+75%0.174-12%
Debt To Asset Ratio--4.4484.715-6%4.022+11%11.262-61%12.365-64%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps---0.001-0.001-10%-0.001-37%0.000-39%-0.001-21%
Free Cash Flow Per Share---0.0010.000-41%0.000-42%0.000-62%0.000-47%
Free Cash Flow To Equity Per Share--0.0010.000+301%0.000+126%0.000+1503%0.000+7040%
Gross Profit Margin--1.0901.101-1%1.013+8%1.039+5%1.117-2%
Intrinsic Value_10Y_max---0.025--------
Intrinsic Value_10Y_min---0.061--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.002--------
Intrinsic Value_3Y_max---0.006--------
Intrinsic Value_3Y_min---0.010--------
Intrinsic Value_5Y_max---0.010--------
Intrinsic Value_5Y_min---0.022--------
Market Cap41846760.960+80%8439096.79432657909.699-74%61950642.371-86%65960956.963-87%39119747.037-78%
Net Profit Margin---6.621-10.601+60%-2.921-56%-4.991-25%-3.775-43%
Operating Margin---5.075-6.149+21%-2.144-58%-3.176-37%-2.509-51%
Operating Ratio--6.0757.064-14%3.125+94%4.139+47%3.556+71%
Pb Ratio-3.643-396%-0.735-3.144+328%-7.119+869%-6.259+752%-4.388+497%
Pe Ratio-18.456-396%-3.722-17.393+367%-45.655+1127%-44.109+1085%-24.912+569%
Price Per Share0.060+80%0.0120.047-74%0.089-86%0.095-87%0.056-78%
Price To Free Cash Flow Ratio-21.004-396%-4.236-41.931+890%33.681-113%58.209-107%13.265-132%
Price To Total Gains Ratio-73.823-396%-14.888-69.573+367%-107.261+620%-235.228+1480%-158.304+963%
Quick Ratio--0.1400.109+28%0.115+22%0.056+150%0.130+7%
Return On Assets---0.170-0.180+6%-0.123-28%-0.384+126%-0.679+299%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.001-0.001-10%0.001-197%0.000-75%0.000-62%
Usd Book Value---11485847.696-10603907.296-8%-8847379.843-23%-10289019.906-10%-7984519.883-30%
Usd Book Value Change Per Share---0.001-0.001-10%0.001-197%0.000-75%0.000-62%
Usd Book Value Per Share---0.016-0.015-8%-0.013-23%-0.015-10%-0.011-31%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.001-10%-0.001-37%0.000-39%-0.001-21%
Usd Free Cash Flow---498075.046-291982.654-41%-288208.825-42%-189032.525-62%-269453.794-46%
Usd Free Cash Flow Per Share---0.0010.000-41%0.000-42%0.000-62%0.000-47%
Usd Free Cash Flow To Equity Per Share--0.0010.000+301%0.000+126%0.000+1503%0.000+7040%
Usd Market Cap41846760.960+80%8439096.79432657909.699-74%61950642.371-86%65960956.963-87%39119747.037-78%
Usd Price Per Share0.060+80%0.0120.047-74%0.089-86%0.095-87%0.056-78%
Usd Profit---566853.504-512760.130-10%-358662.906-37%-347407.556-39%-484321.879-15%
Usd Revenue--85614.95778019.174+10%158125.658-46%179364.141-52%268663.162-68%
Usd Total Gains Per Share---0.001-0.001-10%0.001-197%0.000-75%0.000-62%
 EOD+6 -2MRQTTM+12 -20YOY+8 -245Y+10 -2210Y+8 -24

3.2. Fundamental Score

Let's check the fundamental score of MedMira Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-18.456
Price to Book Ratio (EOD)Between0-1-3.643
Net Profit Margin (MRQ)Greater than0-6.621
Operating Margin (MRQ)Greater than0-5.075
Quick Ratio (MRQ)Greater than10.140
Current Ratio (MRQ)Greater than10.154
Debt to Asset Ratio (MRQ)Less than14.448
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.170
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of MedMira Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.060
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-10-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets4,586
Total Liabilities20,398
Total Stockholder Equity-15,812
 As reported
Total Liabilities 20,398
Total Stockholder Equity+ -15,812
Total Assets = 4,586

Assets

Total Assets4,586
Total Current Assets2,682
Long-term Assets1,904
Total Current Assets
Cash And Cash Equivalents 892
Net Receivables 1,552
Inventory 176
Other Current Assets 61
Total Current Assets  (as reported)2,682
Total Current Assets  (calculated)2,682
+/-0
Long-term Assets
Property Plant Equipment 1,904
Intangible Assets 0
Long-term Assets  (as reported)1,904
Long-term Assets  (calculated)1,904
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities17,458
Long-term Liabilities2,940
Total Stockholder Equity-15,812
Total Current Liabilities
Short-term Debt 6,319
Short Long Term Debt 6,146
Accounts payable 3,234
Other Current Liabilities 7,144
Total Current Liabilities  (as reported)17,458
Total Current Liabilities  (calculated)22,843
+/- 5,385
Long-term Liabilities
Long term Debt 1,135
Capital Lease Obligations 1,978
Long-term Liabilities  (as reported)2,940
Long-term Liabilities  (calculated)3,112
+/- 172
Total Stockholder Equity
Common Stock68,347
Retained Earnings -98,739
Accumulated Other Comprehensive Income 14,578
Total Stockholder Equity (as reported)-15,812
Total Stockholder Equity (calculated)-15,815
+/- 3
Other
Capital Stock68,350
Cash and Short Term Investments 892
Common Stock Shares Outstanding 697,446
Current Deferred Revenue762
Liabilities and Stockholders Equity 4,586
Net Debt 8,366
Net Invested Capital -8,534
Net Working Capital -14,776
Short Long Term Debt Total 9,258



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-04-302017-01-312016-10-312016-07-312016-04-302016-01-312015-10-312015-07-312015-04-302015-01-312014-10-312014-07-312014-04-302014-01-312013-10-312013-07-312013-04-302013-01-312012-10-312012-07-312012-04-302012-01-312011-10-312011-07-312011-04-302011-01-312010-10-312010-07-312010-04-302010-01-312009-10-312009-07-312009-04-302009-01-312008-10-312008-07-312008-04-302008-01-312007-10-312007-07-312007-04-302007-01-312006-10-312006-07-312006-04-302006-01-312005-10-312005-07-312005-04-302005-01-312004-10-312004-07-312004-04-302004-01-312003-10-312003-07-312003-04-302003-01-312002-10-312002-07-312002-04-302002-01-312001-10-312001-07-312001-04-302001-01-312000-10-312000-07-312000-04-302000-01-31
> Total Assets 
312
9,357
7,605
6,007
5,111
3,826
1,975
2,805
2,756
2,682
3,362
2,391
2,009
1,493
2,361
1,591
1,544
1,597
1,694
1,619
1,432
1,617
1,428
1,732
1,973
4,213
4,008
3,796
4,154
3,725
2,864
2,541
2,870
2,551
833
822
764
691
523
491
1,208
1,032
568
616
570
518
1,492
518
592
591
2,970
2,199
1,273
858
1,167
5,728
3,594
1,784
1,842
1,687
1,238
1,282
1,784
4,721
3,890
2,147
870
863
816
699
674
619
348
277
301
289
324
275
253
2,665
2,832
3,098
3,396
4,560
3,999
3,679
3,890
4,868
4,554
4,098
3,830
3,777
3,724
3,829
3,652
4,586
4,5863,6523,8293,7243,7773,8304,0984,5544,8683,8903,6793,9994,5603,3963,0982,8322,6652532753242893012773486196746998168638702,1473,8904,7211,7841,2821,2381,6871,8421,7843,5945,7281,1678581,2732,1992,9705915925181,4925185706165681,0321,2084915236917648228332,5512,8702,5412,8643,7254,1543,7964,0084,2131,9731,7321,4281,6171,4321,6191,6941,5971,5441,5912,3611,4932,0092,3913,3622,6822,7562,8051,9753,8265,1116,0077,6059,357312
   > Total Current Assets 
0
0
0
0
0
0
0
1,924
1,954
1,960
2,720
1,818
1,445
993
1,955
1,190
1,230
1,271
1,421
1,398
1,262
1,443
1,242
1,301
1,637
1,875
1,647
1,488
1,901
1,526
757
626
1,009
744
736
739
692
630
490
441
1,130
958
512
570
532
488
1,460
487
565
495
2,951
2,169
1,172
597
822
5,392
3,216
1,411
1,484
1,352
925
991
1,520
4,465
3,648
1,931
678
695
674
582
581
551
302
245
272
271
310
266
246
130
344
656
911
2,123
1,610
1,342
1,576
2,603
2,340
1,874
1,658
1,658
1,658
1,816
1,692
2,682
2,6821,6921,8161,6581,6581,6581,8742,3402,6031,5761,3421,6102,1239116563441302462663102712722453025515815826746956781,9313,6484,4651,5209919251,3521,4841,4113,2165,3928225971,1722,1692,9514955654871,4604885325705129581,1304414906306927397367441,0096267571,5261,9011,4881,6471,8751,6371,3011,2421,4431,2621,3981,4211,2711,2301,1901,9559931,4451,8182,7201,9601,9541,9240000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
10
38
33
1,037
471
237
72
264
24
28
88
0
87
11
0
29
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
310
28
0
37
0
0
1,027
33
33
0
2,417
1,295
448
24
21
4,555
2,427
284
162
525
127
162
262
3,147
1,633
208
46
166
119
94
156
119
27
0
0
0
0
1
89
-2,549
155
423
402
603
122
5
-2,304
995
937
396
33
15
125
84
13
892
89213841251533396937995-2,3045122603402423155-2,54989100002711915694119166462081,6333,1472621621275251622842,4274,55521244481,2952,417033331,027003702831014000000000000000029011870882824264722374711,0373338100000000
       Short-term Investments 
0
0
0
0
0
0
0
72
72
72
74
74
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000000000000000000000000000074747272720000000
       Net Receivables 
0
0
0
0
0
0
0
134
136
136
143
143
121
108
776
151
117
364
461
497
390
657
492
496
755
870
741
773
856
793
211
150
322
182
190
223
224
185
104
114
392
570
93
101
91
81
109
102
136
114
164
504
280
278
526
572
381
710
971
464
394
516
919
980
1,569
1,297
286
214
194
204
172
187
40
19
73
76
104
71
39
15
70
44
208
1,130
1,106
1,013
1,251
1,302
1,099
1,200
1,369
1,390
1,298
1,508
1,427
1,552
1,5521,4271,5081,2981,3901,3691,2001,0991,3021,2511,0131,1061,1302084470153971104767319401871722041942142861,2971,5699809195163944649717103815725262782805041641141361021098191101935703921141041852242231901823221502117938567737418707554964926573904974613641171517761081211431431361361340000000
       Other Current Assets 
0
699
728
923
848
538
63
446
446
446
464
179
18
18
114
114
120
10
125
158
224
183
185
108
294
279
178
59
392
205
55
43
253
138
73
70
44
34
69
0
103
75
58
33
73
84
109
114
134
130
144
138
210
130
70
0
0
165
48
64
50
34
39
36
125
91
52
30
81
30
26
34
24
22
0
12
25
23
12
2,560
17
80
79
50
92
72
2,394
82
86
42
54
60
50
45
69
61
6169455060544286822,3947292507980172,5601223251202224342630813052911253639345064481650070130210138144130134114109847333587510306934447073138253435520539259178279294108185183224158125101201141141818179464446446446635388489237286990
   > Long-term Assets 
0
0
0
0
0
0
0
881
803
723
642
573
564
500
406
401
314
326
272
220
170
174
186
432
337
2,337
2,361
2,308
2,254
2,199
2,107
1,915
1,861
1,806
97
83
72
61
34
49
77
74
56
47
38
30
33
31
26
96
19
30
102
262
345
336
378
373
358
335
313
291
264
256
242
217
191
168
142
117
92
68
46
33
29
19
13
9
7
2,534
2,488
2,442
2,485
2,437
2,389
2,337
2,314
2,265
2,214
2,224
2,171
2,119
2,066
2,013
1,960
1,904
1,9041,9602,0132,0662,1192,1712,2242,2142,2652,3142,3372,3892,4372,4852,4422,4882,53479131929334668921171421681912172422562642913133353583733783363452621023019962631333038475674774934617283971,8061,8611,9152,1072,1992,2542,3082,3612,3373374321861741702202723263144014065005645736427238038810000000
       Property Plant Equipment 
0
624
688
629
671
670
627
881
803
723
642
573
564
500
406
401
314
326
272
220
170
174
165
159
161
161
224
209
193
177
161
145
129
113
97
83
72
61
34
49
77
74
56
47
38
30
32
31
26
24
19
30
102
262
345
336
378
373
358
335
313
291
264
256
242
217
191
168
142
117
92
68
46
33
29
19
13
9
7
2,534
2,488
2,442
2,485
2,437
2,389
2,337
2,314
2,265
2,214
2,224
2,171
2,119
2,066
2,013
1,960
1,904
1,9041,9602,0132,0662,1192,1712,2242,2142,2652,3142,3372,3892,4372,4852,4422,4882,53479131929334668921171421681912172422562642913133353583733783363452621023019242631323038475674774934617283971131291451611771932092241611611591651741702202723263144014065005645736427238038816276706716296886240
       Intangible Assets 
0
0
293
262
242
213
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,799
1,734
1,714
1,886
1,665
1,695
1,770
1,732
1,693
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000001,6931,7321,7701,6951,6651,8861,7141,7341,799000000000000000000021324226229300
       Other Assets 
0
327
293
262
242
213
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
17
230
154
1,956
1,888
1,870
1,751
1,823
1,823
1,875
1,725
1,681
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000002000001,6811,7251,8751,8231,8231,7511,8701,8881,9561542301710000000000000002132422622933270
> Total Liabilities 
11
6,675
6,804
6,255
6,322
6,186
5,892
9,992
10,866
11,386
10,810
10,693
10,412
11,486
4,547
4,711
5,662
6,533
7,567
7,999
9,201
9,475
11,233
13,228
14,528
10,345
12,054
13,131
14,432
14,716
15,642
15,961
15,433
14,228
14,774
15,899
16,172
16,499
16,520
15,848
15,525
15,973
17,232
18,398
18,662
19,491
20,606
21,476
21,894
23,503
11,679
10,765
8,765
9,210
10,277
9,607
8,890
8,298
8,532
8,326
8,914
8,688
9,488
8,351
8,476
7,947
8,532
8,538
8,504
9,138
9,658
10,158
10,601
11,173
11,699
12,203
12,867
13,331
13,769
16,650
17,432
18,391
18,958
19,408
19,247
19,265
19,614
21,084
16,035
15,991
16,186
16,765
17,203
17,898
18,683
20,398
20,39818,68317,89817,20316,76516,18615,99116,03521,08419,61419,26519,24719,40818,95818,39117,43216,65013,76913,33112,86712,20311,69911,17310,60110,1589,6589,1388,5048,5388,5327,9478,4768,3519,4888,6888,9148,3268,5328,2988,8909,60710,2779,2108,76510,76511,67923,50321,89421,47620,60619,49118,66218,39817,23215,97315,52515,84816,52016,49916,17215,89914,77414,22815,43315,96115,64214,71614,43213,13112,05410,34514,52813,22811,2339,4759,2017,9997,5676,5335,6624,7114,54711,48610,41210,69310,81011,38610,8669,9925,8926,1866,3226,2556,8046,67511
   > Total Current Liabilities 
11
753
1,056
650
635
645
344
1,101
1,514
2,806
2,302
2,134
1,864
2,949
3,922
4,086
5,006
5,878
5,948
5,232
6,758
7,139
10,300
12,495
12,365
8,343
10,580
11,825
13,398
13,747
14,568
14,828
14,239
10,822
13,665
14,307
14,603
15,299
15,584
11,626
11,044
11,600
16,802
18,398
18,662
19,491
20,606
21,133
21,532
23,050
11,049
2,967
3,040
3,694
4,854
4,354
3,792
3,456
4,286
5,061
5,754
5,765
6,993
3,940
4,723
5,746
8,277
8,538
8,218
8,401
9,421
10,158
10,601
11,173
11,699
12,203
12,867
13,331
13,769
14,233
15,053
16,009
15,806
16,300
16,763
17,026
17,415
18,912
13,905
13,901
14,138
14,393
14,631
14,886
15,726
17,458
17,45815,72614,88614,63114,39314,13813,90113,90518,91217,41517,02616,76316,30015,80616,00915,05314,23313,76913,33112,86712,20311,69911,17310,60110,1589,4218,4018,2188,5388,2775,7464,7233,9406,9935,7655,7545,0614,2863,4563,7924,3544,8543,6943,0402,96711,04923,05021,53221,13320,60619,49118,66218,39816,80211,60011,04411,62615,58415,29914,60314,30713,66510,82214,23914,82814,56813,74713,39811,82510,5808,34312,36512,49510,3007,1396,7585,2325,9485,8785,0064,0863,9222,9491,8642,1342,3022,8061,5141,1013446456356501,05675311
       Short-term Debt 
0
0
0
0
0
0
0
29
12
1,404
980
980
530
1,005
1,298
1,378
1,635
2,769
3,014
3,598
4,247
4,715
7,236
9,862
8,979
6,258
7,961
8,709
9,529
9,601
9,154
8,613
9,030
6,601
9,604
9,636
10,594
10,671
10,787
6,814
4,905
7,566
12,324
13,329
14,562
14,715
14,654
14,509
17,100
17,018
7,185
441
785
1,244
2,191
1,844
1,781
1,704
2,235
3,405
3,733
3,784
4,721
2,305
2,657
4,030
5,994
6,263
5,958
5,953
6,702
7,319
7,411
7,539
7,584
7,979
8,199
8,250
8,610
8,866
9,441
9,578
8,759
8,721
9,246
9,274
9,336
9,330
6,269
6,264
6,251
6,256
6,312
6,310
6,314
6,319
6,3196,3146,3106,3126,2566,2516,2646,2699,3309,3369,2749,2468,7218,7599,5789,4418,8668,6108,2508,1997,9797,5847,5397,4117,3196,7025,9535,9586,2635,9944,0302,6572,3054,7213,7843,7333,4052,2351,7041,7811,8442,1911,2447854417,18517,01817,10014,50914,65414,71514,56213,32912,3247,5664,9056,81410,78710,67110,5949,6369,6046,6019,0308,6139,1549,6019,5298,7097,9616,2588,9799,8627,2364,7154,2473,5983,0142,7691,6351,3781,2981,0055309809801,40412290000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,855
4,782
4,803
5,036
6,207
6,160
6,158
6,153
6,146
6,147
6,148
9,307
9,442
8,621
8,582
9,105
9,131
9,192
9,184
6,121
6,114
6,100
6,102
6,152
6,145
6,145
6,146
6,1466,1456,1456,1526,1026,1006,1146,1219,1849,1929,1319,1058,5828,6219,4429,3076,1486,1476,1466,1536,1586,1606,2075,0364,8034,7824,855000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
11
525
754
400
390
414
250
1,072
1,501
1,402
1,260
1,154
1,334
1,944
2,606
2,701
3,371
3,109
2,933
1,634
2,512
2,425
3,064
2,633
3,386
2,084
2,619
3,116
3,838
4,089
4,954
5,427
4,510
3,642
3,448
3,826
2,661
3,289
3,834
3,820
4,034
3,341
3,799
4,463
3,400
4,474
5,548
6,003
3,752
5,451
3,280
2,464
2,193
2,358
2,560
2,419
1,865
1,638
1,848
1,477
1,870
1,977
2,265
1,602
2,048
1,688
2,241
2,275
2,252
2,447
1,741
1,783
1,981
2,169
2,339
2,299
2,432
2,653
2,480
2,473
2,433
2,479
2,314
2,442
2,386
2,549
2,700
2,608
2,454
2,570
2,750
2,832
2,719
2,844
3,263
3,234
3,2343,2632,8442,7192,8322,7502,5702,4542,6082,7002,5492,3862,4422,3142,4792,4332,4732,4802,6532,4322,2992,3392,1691,9811,7831,7412,4472,2522,2752,2411,6882,0481,6022,2651,9771,8701,4771,8481,6381,8652,4192,5602,3582,1932,4643,2805,4513,7526,0035,5484,4743,4004,4633,7993,3414,0343,8203,8343,2892,6613,8263,4483,6424,5105,4274,9544,0893,8383,1162,6192,0843,3862,6333,0642,4252,5121,6342,9333,1093,3712,7012,6061,9441,3341,1541,2601,4021,5011,07225041439040075452511
       Other Current Liabilities 
0
195
231
217
212
199
69
0
0
0
62
0
0
0
18
7
0
0
0
0
0
0
0
0
0
0
0
0
26
52
431
835
696
575
598
697
3,307
3,927
4,133
4,117
5,506
3,400
3,887
4,534
3,404
4,253
5,308
6,001
3,763
5,381
3,290
2,463
61
91
100
0
131
104
186
159
121
2
5
24
13
22
31
0
5
69
978
1,056
2,392
2,870
3,500
3,825
4,447
4,830
5,334
5,763
6,335
6,591
6,985
7,455
7,720
7,992
8,361
5,951
4,344
4,449
4,540
4,669
4,798
4,960
5,400
7,144
7,1445,4004,9604,7984,6694,5404,4494,3445,9518,3617,9927,7207,4556,9856,5916,3355,7635,3344,8304,4473,8253,5002,8702,3921,05697869503122132452121159186104131010091612,4633,2905,3813,7636,0015,3084,2533,4044,5343,8873,4005,5064,1174,1333,9273,307697598575696835431522600000000000071800062000691992122172311950
   > Long-term Liabilities 
0
0
0
0
0
0
0
8,892
9,353
8,581
8,508
8,559
8,548
8,537
625
625
655
655
1,620
2,767
2,442
2,335
933
733
2,163
2,003
1,474
1,305
1,033
969
1,074
1,133
1,194
3,406
1,109
1,592
1,569
1,200
937
4,223
4,481
4,374
430
0
0
0
0
343
362
453
629
7,798
5,726
5,516
5,423
5,253
5,097
4,842
4,246
3,265
3,159
2,923
2,495
4,412
3,753
2,201
255
0
286
737
237
0
0
0
0
0
0
0
0
2,417
2,379
2,382
3,152
3,108
2,484
2,239
2,199
2,172
2,131
2,089
2,048
2,372
2,572
3,012
2,957
2,940
2,9402,9573,0122,5722,3722,0482,0892,1312,1722,1992,2392,4843,1083,1522,3822,3792,4170000000023773728602552,2013,7534,4122,4952,9233,1593,2654,2464,8425,0975,2535,4235,5165,7267,79862945336234300004304,3744,4814,2239371,2001,5691,5921,1093,4061,1941,1331,0749691,0331,3051,4742,0032,1637339332,3352,4422,7671,6206556556256258,5378,5488,5598,5088,5819,3538,8920000000
       Other Liabilities 
0
135
0
0
0
0
0
59
53
47
0
33
26
21
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
343
361
386
400
423
446
466
720
731
686
696
238
231
207
439
199
199
186
208
0
0
0
36
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000360002081861991994392072312386966867317204664464234003863613430000000000000000000000000000000002126330475359000001350
> Total Stockholder Equity
301
2,682
801
0
0
0
0
-7,187
-8,110
-8,704
-7,447
-8,302
-8,403
-9,993
-2,187
-3,120
-4,117
-4,936
-5,874
-6,381
-7,769
-7,858
-9,805
-11,496
-12,555
-6,133
-8,046
-9,334
-10,278
-10,991
-12,778
-13,420
-12,563
-11,677
-13,941
-15,077
-15,408
-15,808
-15,997
-15,358
-14,317
-14,941
-16,664
-17,782
-18,092
-18,974
-19,114
-20,958
-21,302
-22,912
-8,708
-8,566
-7,492
-8,352
-9,111
-3,879
-5,296
-6,514
-6,690
-6,639
-7,676
-7,406
-7,704
-3,630
-4,586
-5,800
-7,662
-7,675
-7,687
-8,439
-8,985
-9,539
-10,253
-10,895
-11,398
-11,914
-12,543
-13,056
-13,517
-13,986
-14,600
-15,292
-15,562
-14,847
-15,248
-15,586
-15,724
-16,215
-11,482
-11,893
-12,356
-12,988
-13,479
-14,069
-15,032
-15,812
-15,812-15,032-14,069-13,479-12,988-12,356-11,893-11,482-16,215-15,724-15,586-15,248-14,847-15,562-15,292-14,600-13,986-13,517-13,056-12,543-11,914-11,398-10,895-10,253-9,539-8,985-8,439-7,687-7,675-7,662-5,800-4,586-3,630-7,704-7,406-7,676-6,639-6,690-6,514-5,296-3,879-9,111-8,352-7,492-8,566-8,708-22,912-21,302-20,958-19,114-18,974-18,092-17,782-16,664-14,941-14,317-15,358-15,997-15,808-15,408-15,077-13,941-11,677-12,563-13,420-12,778-10,991-10,278-9,334-8,046-6,133-12,555-11,496-9,805-7,858-7,769-6,381-5,874-4,936-4,117-3,120-2,187-9,993-8,403-8,302-7,447-8,704-8,110-7,18700008012,682301
   Common Stock
301
0
8,301
8,104
8,234
8,036
8,046
7,766
7,778
8,189
10,433
10,752
11,701
12,474
18,796
20,032
19,771
19,521
20,045
22,379
22,068
22,810
23,604
24,207
24,952
33,305
32,897
33,309
32,121
34,439
36,054
41,483
40,468
42,579
43,114
36,900
36,700
38,678
46,930
48,642
50,639
50,639
48,375
48,711
50,056
51,443
53,290
51,003
51,458
52,276
55,487
55,692
55,661
55,661
55,661
59,018
59,018
59,018
59,018
59,652
59,652
60,287
60,211
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,422
63,437
63,437
63,904
63,902
68,350
68,350
68,350
68,350
68,350
68,347
68,347
68,347
68,34768,34768,34768,35068,35068,35068,35068,35063,90263,90463,43763,43763,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42263,42260,21160,28759,65259,65259,01859,01859,01859,01855,66155,66155,66155,69255,48752,27651,45851,00353,29051,44350,05648,71148,37550,63950,63948,64246,93038,67836,70036,90043,11442,57940,46841,48336,05434,43932,12133,30932,89733,30524,95224,20723,60422,81022,06822,37920,04519,52119,77120,03218,79612,47411,70110,75210,4338,1897,7787,7668,0468,0368,2348,1048,3010301
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
209
209
209
271
330
0
0
0
736
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-34
-66
-66
6,189
6,189
596
596
596
596
596
596
596
596
596
596
596
596
596
596
1,066
1,855
2,376
2,376
2,388
2,470
2,470
2,470
9,458
2,470
10,271
11,058
11,046
13,772
13,782
13,782
13,782
13,782
13,792
13,792
13,792
13,792
13,792
13,824
14,578
14,578
14,578
14,578
14,578
14,578
14,57814,57814,57814,57814,57814,57813,82413,79213,79213,79213,79213,79213,78213,78213,78213,78213,77211,04611,05810,2712,4709,4582,4702,4702,4702,3882,3762,3761,8551,0665965965965965965965965965965965965965965966,1896,189-66-66-3400000000000000000007360003302712092092090000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
12,346
12,346
12,846
16,564
16,764
17,809
17,916
26,440
26,400
26,432
26,746
26,746
27,413
27,413
28,641
28,651
28,655
29,095
37,721
37,968
37,421
38,726
39,179
39,523
40,356
41,845
44,109
45,379
45,991
46,856
47,433
1,656
1,656
1,656
1,656
52,337
52,331
53,325
1,882
54,780
54,849
55,843
55,843
55,661
55,661
5,593
5,593
5,593
8,307
8,307
8,307
8,491
8,952
8,952
9,439
9,514
11,278
11,304
11,304
22,603
11,304
11,320
11,320
11,320
11,320
11,320
11,335
4,346
11,335
3,533
2,746
2,746
20
10
10
10
10
13,792
13,792
32
32
786
754
14,578
-3
-3
0
0
0
000-3-314,578754786323213,79213,79210101010202,7462,7463,53311,3354,34611,33511,32011,32011,32011,32011,32011,30422,60311,30411,30411,2789,5149,4398,9528,9528,4918,3078,3078,3075,5935,5935,59355,66155,66155,84355,84354,84954,7801,88253,32552,33152,3371,6561,6561,6561,65647,43346,85645,99145,37944,10941,84540,35639,52339,17938,72637,42137,96837,72129,09528,65528,65128,64127,41327,41326,74626,74626,43226,40026,44017,91617,80916,76416,56412,84612,34612,3460000000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-07-31)

Gross Profit (+$)
totalRevenue433
Cost of Revenue-132
Gross Profit300300
 
Operating Income (+$)
Gross Profit300
Operating Expense-2,079
Operating Income-1,944-1,778
 
Operating Expense (+$)
Research Development471
Selling General Administrative843
Selling And Marketing Expenses196
Operating Expense2,0791,509
 
Net Interest Income (+$)
Interest Income-
Interest Expense-886
Other Finance Cost-12
Net Interest Income-898
 
Pretax Income (+$)
Operating Income-1,944
Net Interest Income-898
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-2,676-1,213
EBIT - interestExpense = -2,676
-2,521
-1,790
Interest Expense886
Earnings Before Interest and Taxes (EBIT)-1,790-1,790
Earnings Before Interest and Taxes (EBITDA)-1,577
 
After tax Income (+$)
Income Before Tax-2,676
Tax Provision--
Net Income From Continuing Ops-2,676-2,676
Net Income-2,676
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses2,211
Total Other Income/Expenses Net-731898
 

Technical Analysis of Medmira
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medmira. The general trend of Medmira is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medmira's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MedMira Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.0616 < 0.0616 < 0.0616.

The bearish price targets are: 0.035 > 0.035 > 0.035.

Tweet this
MedMira Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MedMira Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MedMira Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MedMira Inc.

MedMira Inc Daily Moving Average Convergence/Divergence (MACD) ChartMedMira Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MedMira Inc. The current adx is .

MedMira Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MedMira Inc.

MedMira Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MedMira Inc.

MedMira Inc Daily Relative Strength Index (RSI) ChartMedMira Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MedMira Inc.

MedMira Inc Daily Stochastic Oscillator ChartMedMira Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MedMira Inc.

MedMira Inc Daily Commodity Channel Index (CCI) ChartMedMira Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MedMira Inc.

MedMira Inc Daily Chande Momentum Oscillator (CMO) ChartMedMira Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MedMira Inc.

MedMira Inc Daily Williams %R ChartMedMira Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MedMira Inc.

MedMira Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MedMira Inc.

MedMira Inc Daily Average True Range (ATR) ChartMedMira Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MedMira Inc.

MedMira Inc Daily On-Balance Volume (OBV) ChartMedMira Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MedMira Inc.

MedMira Inc Daily Money Flow Index (MFI) ChartMedMira Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MedMira Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

MedMira Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MedMira Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.060
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medmira with someone you think should read this too:
  • Are you bullish or bearish on Medmira? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medmira? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MedMira Inc

I send you an email if I find something interesting about MedMira Inc.


Comments

How you think about this?

Leave a comment

Stay informed about MedMira Inc.

Receive notifications about MedMira Inc in your mailbox!